Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Nicola Blackwood, the MP for Oxford West and Abingdon, spent the day in Nuffield Department of Surgical Sciences with Professor Kathryn Wood and her research group, Transplantation Research Immunology Group (TRIG) last Friday, 17th January 2014. This was a reciprocal visit arranged through the Royal Society’s MP- Scientist pairing scheme which aims to build bridges between parliamentarians and some of the best scientists in the UK.

The aim of the visit was to demonstrate how translational research is taken from “bench to bedside”, and how discoveries made in the lab can eventually impact the treatments that patients receive.

During the day, Nicola met with Kathryn and the group and had the opportunity to discuss the group’s portfolio of research and see some of the different techniques used in the lab such as how stem cells are grown, and how cells are sorted and imaged.  Nicola also visited the Oxford Transplant Centre where she met Professor Peter Friend and some of the staff and patients.

2014-01-24 Pairing SchemeAt the end of the day, Nicola tweeted:   “Just spent an amazing day with Prof Wood's transplant & Immunology team at JR …”   

Image: from left to right: Kathryn Wood, Nicola Blackwood, Liz Wallin 

Link: 

Nuffield Department of Surgical Sciences  

Transplantation Research Immunology Group

Nicola Blackwood

Similar stories

Just over half of British Indians would take COVID vaccine

Coronavirus COVID-19 General Research

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Investigating New Treatment for Schizophrenia

General Innovation Research

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.

Parental mental health worsens under new national COVID-19 restrictions

Coronavirus COVID-19 General Research

Parental stress, depression and anxiety have again increased since new national restrictions have been introduced, according to the latest report from the Oxford University-led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study, based on data from over 6000 UK parents.

£100 million donation from Ineos to create new institute to fight antimicrobial resistance

Awards and Appointments General Innovation

A new state of the art institute for antimicrobial research is to open at Oxford University thanks to a £100 million donation from Ineos.